Spatial and temporal control of age-related APP processing in genomic-based β-secretase transgenic mice

Neurobiology of Aging

Volumn 28, Issue 1, 2007, Pages 75-84

  Chiocco, Matthew J ^a   Lamb, Bruce T ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Secretase; Alzheimer's disease; Amyloid ; Genomic based

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENOMICS; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; TRANSGENIC MOUSE;

AGING; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; BRAIN; GENOMICS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 33751243918     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2005.11.011     Document Type: Article

References (41)

1. Basha M.R., Wei W., Bakheet S.A., Benitez N., Siddiqi H.K., Ge Y.W., et al. The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. J Neurosci 4 25 (2005) 823-829
2. Bodendorf U., Danner S., Fischer F., Stefani M., Sturchler-Pierrat C., Wiederhold K.H., et al. Expression of human beta-secretase in the mouse brain increases the steady-state level of beta-amyloid. J Neurochem 80 5 (2002) 799-806
3. Braak H., and Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18 4 (1997) 351-357
4. Chiocco M.J., Kulnane L.S., Younkin L., Younkin S., Evin G., and Lamb B.T. Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic mice. J Biol Chem 279 50 (2004) 52535-52542
5. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A.Y., Seubert P., et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360 6405 (1992) 672-674
6. Cordy J.M., Hussain I., Dingwall C., Hooper N.M., and Turner A.J. Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc Natl Acad Sci USA 100 20 (2003) 11735-11740
7. Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9 7 (2003) 907-913
8. Farris W., Mansourian S., Leissring M.A., Eckman E.A., Bertram L., Eckman C.B., et al. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol 164 4 (2004) 1425-1434
9. Fukumoto H., Cheung B.S., Hyman B.T., and Irizarry M.C. Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 59 9 (2002) 1381-1389
10. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349 6311 (1991) 704-706
11. Haass C., Hung A.Y., Selkoe D.J., and Teplow D.B. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. J Biol Chem 269 26 (1994) 17741-17748
12. He W., Lu Y., Qahwash I., Hu X.Y., Chang A., and Yan R. Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation. Nat Med 10 9 (2004) 959-965
13. Hendriks L., van Duijn C.M., Cras P., Cruts M., Van Hul W., van Harskamp F., et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1 3 (1992) 218-221
14. Iwata N., Tsubuki S., Takaki Y., Shirotani K., Lu B., Gerard N.P., et al. Metabolic regulation of brain Abeta by neprilysin. Science 292 5521 (2001) 1550-1552
15. Johnson-Wood K., Lee M., Motter R., Hu K., Gordon G., Barbour R., et al. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci USA 94 4 (1997) 1550-1555
16. Kang D.E., Pietrzik C.U., Baum L., Chevallier N., Merriam D.E., Kounnas M.Z., et al. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest 106 9 (2000) 1159-1166
17. Kulnane L.S., and Lamb B.T. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice. Neurobiol Dis 8 6 (2001) 982-992
18. Lahiri D.K., Nall C., Chen D., Zaphiriou M., Morgan C., and Nurnberger Sr. J.I. Developmental expression of the beta-amyloid precursor protein and heat-shock protein 70 in the cerebral hemisphere region of the rat brain. Ann N Y Acad Sci 965 (2002) 324-333
19. Lamb B.T., Call L.M., Slunt H.H., Bardel K.A., Lawler A.M., Eckman C.B., et al. Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice. Hum Mol Genet 6 9 (1997) 1535-1541
20. Lehman E.J., Kulnane L.S., Gao Y., Petriello M.C., Pimpis K.M., Younkin L., et al. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse. Hum Mol Genet 12 22 (2003) 2949-2956
21. Lehman E.J., Kulnane L.S., and Lamb B.T. Alterations in beta-amyloid production and deposition in brain regions of two transgenic models. Neurobiol Aging 24 5 (2003) 645-653
22. Leissring M.A., Farris W., Chang A.Y., Walsh D.M., Wu X., Sun X., et al. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40 6 (2003) 1087-1093
23. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269 5226 (1995) 973-977
24. Loffler J., and Huber G. Beta-amyloid precursor protein isoforms in various rat brain regions and during brain development. J Neurochem 59 4 (1992) 1316-1324
25. Luo Y., Bolon B., Kahn S., Bennett B.D., Babu-Khan S., Denis P., et al. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci 4 3 (2001) 231-232
26. Marcinkiewicz M., and Seidah N.G. Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain. J Neurochem 75 5 (2000) 2133-2143
27. Marr R.A., Rockenstein E., Mukherjee A., Kindy M.S., Hersh L.B., Gage F.H., et al. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci 23 6 (2003) 1992-1996
28. Mohajeri M.H., Saini K.D., and Nitsch R.M. Transgenic BACE expression in mouse neurons accelerates amyloid plaque pathology. J Neural Transm 111 3 (2004) 413-425
29. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1 5 (1992) 345-347
30. Pastorino L., Ikin A.F., Lamprianou S., Vacaresse N., Revelli J.P., Platt K., et al. BACE (beta-secretase) modulates the processing of APLP2 in vivo. Mol Cell Neurosci 25 4 (2004) 642-649
31. Paxinos G., and Keith B.J. The mouse brain in stereotaxic coordinates. IInd ed. (2001), Academic Press, San Diego
32. Riddell D.R., Christie G., Hussain I., and Dingwall C. Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr Biol 11 16 (2001) 1288-1293
33. Rocchi A., Pellegrini S., Siciliano G., and Murri L. Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res Bull 61 1 (2003) 1-24
34. Shibata M., Yamada S., Kumar S.R., Calero M., Bading J., Frangione B., et al. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106 12 (2000) 1489-1499
35. Sidera C., Parsons R., and Austen B. Post-translational processing of beta-secretase in Alzheimer's disease. Proteomics 5 6 (2005) 1533-1543
36. Sinha S., Anderson J.P., Barbour R., Basi G.S., Caccavello R., Davis D., et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402 6761 (1999) 537-540
37. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286 5440 (1999) 735-741
38. Willem M., Dewachter I., Smyth N., Van Dooren T., Borghgraef P., Haass C., et al. beta-site amyloid precursor protein cleaving enzyme 1 increases amyloid deposition in brain parenchyma but reduces cerebrovascular amyloid angiopathy in aging BACE x APP[V717I] double-transgenic mice. Am J Pathol 165 5 (2004) 1621-1631
39. Xie J., and Guo Q. PAR-4 is involved in regulation of beta-secretase cleavage of the Alzheimer amyloid precursor protein. J Biol Chem 280 14 (2005) 13824-13832
40. Yan R., Bienkowski M.J., Shuck M.E., Miao H., Tory M.C., Pauley A.M., et al. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402 6761 (1999) 533-537
41. Zuchner T., Perez-Polo J.R., and Schliebs R. Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signalling. J Neurosci Res 77 2 (2004) 250-257